In vitro interaction of HMG-CoA reductase inhibitors (statins) with MDR1, MRP2, and OATP-C

被引:0
|
作者
Chen, CP [1 ]
Mireles, R [1 ]
Campbell, S [1 ]
Lin, J [1 ]
Mills, J [1 ]
Xu, J [1 ]
Smolarek, T [1 ]
机构
[1] Pfizer Inc, Groton Lab, Groton, CT 06340 USA
关键词
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
303
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [1] Difference in interactions between HMG-CoA reductase inhibitors with human, rat, and mouse MDR1
    Pimprale, Satish
    Bourgea, Joanne
    Stresser, David
    Patten, Christopher
    Crespi, Charles
    Xiao, Guangqing
    DRUG METABOLISM REVIEWS, 2006, 38 : 55 - 55
  • [2] Statins (HMG-CoA reductase inhibitors), cholesterol and stroke
    Marta-Moreno, J
    Echeandia, C
    Oliveros-Cid, A
    Figuerola, A
    Mola, S
    REVISTA DE NEUROLOGIA, 1998, 27 (159) : 827 - 830
  • [3] HMG-CoA reductase inhibitors (statins) as anticancer drugs (Review)
    Fritz, G
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2005, 27 (05) : 1401 - 1409
  • [4] Potential use of HMG-CoA reductase inhibitors (statins) as radioprotective agents
    Fritz, Gerhard
    Henninger, Christian
    Huelsenbeck, Johannes
    BRITISH MEDICAL BULLETIN, 2011, 97 (01) : 17 - 26
  • [5] OATP-mediated Intestinal Absorption of HMG-COA Reductase Inhibitors in Rats
    Suzuki, Kensuke
    Shirasaka, Yoshiyuki
    Nakanishi, Takeo
    Tamai, Ikumi
    DRUG METABOLISM REVIEWS, 2009, 41 : 24 - 25
  • [6] HMG-CoA reductase inhibitors (statins) - A promising approach to stroke prevention
    Hess, DC
    Demchuk, AM
    Brass, LM
    Yatsu, FM
    NEUROLOGY, 2000, 54 (04) : 790 - 796
  • [7] Inflammation, immunity, and HMG-CoA reductase inhibitors -: Statins as antiinflammatory agents?
    Schönbeck, U
    Libby, P
    CIRCULATION, 2004, 109 (21) : 18 - 26
  • [8] Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density
    Funkhouser, HL
    Adera, T
    Adler, RA
    JOURNAL OF CLINICAL DENSITOMETRY, 2002, 5 (02) : 151 - 158
  • [9] The potential antigoitrogenic effect of HMG-CoA reductase inhibitors (statins) in man
    Hegedus, Laszlo
    CLINICAL ENDOCRINOLOGY, 2008, 68 (01) : 2 - 3
  • [10] HMG-CoA reductase inhibitors (statins): A promising approach to stroke prevention
    Di Napoli, M
    NEUROLOGY, 2000, 55 (07) : 1066 - 1066